Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	vesicle cargo loading	CTAGE9 CTAGE6 SEC24C CTAGE8 CTAGE15 CTAGE4	4.48e-08	36	115	6	GO:0035459
GeneOntologyCellularComponent	endoplasmic reticulum exit site	CTAGE9 CTAGE6 SEC24C CTAGE8 CTAGE15 CTAGE4	1.20e-07	42	117	6	GO:0070971
Domain	Serine_rich	CASS4 NEDD9	9.36e-05	3	105	2	IPR014928
Domain	Serine_rich	CASS4 NEDD9	9.36e-05	3	105	2	PF08824
Domain	SCD	STAG3 STAG2	1.86e-04	4	105	2	PS51425
Domain	SCD	STAG3 STAG2	1.86e-04	4	105	2	IPR020839
Domain	STAG	STAG3 STAG2	1.86e-04	4	105	2	PF08514
Domain	CAS_DUF3513	CASS4 NEDD9	1.86e-04	4	105	2	IPR021901
Domain	STAG	STAG3 STAG2	1.86e-04	4	105	2	IPR013721
Domain	DUF3513	CASS4 NEDD9	1.86e-04	4	105	2	PF12026
Domain	PAS	NCOA3 SIM1 KCNH6	3.63e-04	25	105	3	PF00989
Domain	PAS_fold	NCOA3 SIM1 KCNH6	3.63e-04	25	105	3	IPR013767
Domain	Lambda_DNA-bd_dom	POU6F2 ZNF446 SATB1	5.67e-04	29	105	3	IPR010982
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FAM193B PNPLA2 KMT2B CTC1 BICRA OBSCN ARHGAP17 ATG2A WNK1 HDAC7 CYREN PIK3C2B MARK4 PKD1 FLCN CEP131 CEP170B TOP3A ZNF687	6.27e-09	1105	118	19	35748872
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KIF13B CAD RBM33 ARHGAP17 DAXX TACC2 MAP7 WNK1 PIK3C2B CEP131 CEP170B TOP3A	8.18e-07	588	118	12	38580884
Pubmed	Embryonic temporal-spatial delineation of excitatory spinal V3 interneuron diversity.	POU6F2 SIM1 SP8 ROBO3	8.78e-07	22	118	4	38160393
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	IRF2BP2 NCOA3 DNAJC13 KMT2B PDPK1 DAXX HDAC7 NOL4L SEC24C CBFA2T2 KAT6B STAG2 ZNF687	2.42e-06	774	118	13	15302935
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	TET2 CAD BICRA MAP7 KHSRP SPINDOC STAG3 STAG2	4.40e-06	272	118	8	31010829
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MIIP TET2 KIF13B ARHGAP17 MAP7 WNK1 HDAC7 PIK3C2B CASKIN2 MARK4 CEP131 BRD1 CEP170B	7.63e-06	861	118	13	36931259
Pubmed	Daxx inhibits muscle differentiation by repressing E2A-mediated transcription.	TCF3 DAXX	1.14e-05	2	118	2	19308989
Pubmed	A complex RARE is required for the majority of Nedd9 embryonic expression.	NEDD9 PKD1	1.14e-05	2	118	2	25120220
Pubmed	Desnutrin/ATGL activates PPARδ to promote mitochondrial function for insulin secretion in islet β cells.	PNPLA2 PPARD	1.14e-05	2	118	2	24268737
Pubmed	Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells.	FN1 PPARD	1.14e-05	2	118	2	19935699
Pubmed	Nedd9 restrains renal cystogenesis in Pkd1-/- mice.	NEDD9 PKD1	1.14e-05	2	118	2	25139996
Pubmed	Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.	STAG3 STAG2	1.14e-05	2	118	2	27500726
Pubmed	G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney disease.	PKD1 GPSM1	1.14e-05	2	118	2	23236168
Pubmed	The relationship of promoter methylation of calcium voltage-gated channel alpha 1 and interleukin-16 to primary osteoarthritis.	IL16 CACNA1G	1.14e-05	2	118	2	37259724
Pubmed	Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival.	PDPK1 SGK3	1.14e-05	2	118	2	32926495
Pubmed	Peroxisomal targeting as a tool for assaying potein-protein interactions in the living cell: cytokine-independent survival kinase (CISK) binds PDK-1 in vivo in a phosphorylation-dependent manner.	PDPK1 SGK3	1.14e-05	2	118	2	14604990
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TET2 NCOA3 TCF3 RBM33 BICRA FAM222B	1.39e-05	152	118	6	38360978
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	CTAGE9 FAM193B RAB31 RBM33 OBSCN TACC2 PPARD AFAP1L2 AARS2 CBFA2T2 CTAGE8 PKD1 PEX16 ROBO3 CEP170B	1.62e-05	1215	118	15	15146197
Pubmed	Human transcription factor protein interaction networks.	TET2 IRF2BP2 NCOA3 TCF3 CAD KMT2B RBM33 BICRA ETV7 MAP7 DCAF5 NOL4L SATB1 GLI2 CEP131 ZNF687	2.72e-05	1429	118	16	35140242
Pubmed	Helt determines GABAergic over glutamatergic neuronal fate by repressing Ngn genes in the developing mesencephalon.	SIM1 LHX5 NKX6-1	2.99e-05	18	118	3	17611227
Pubmed	The transcription factors Nkx2.2 and Nkx2.9 play a novel role in floor plate development and commissural axon guidance.	SIM1 NKX6-1 ROBO3	2.99e-05	18	118	3	21068056
Pubmed	Interaction of the leucine-rich repeats of polycystin-1 with extracellular matrix proteins: possible role in cell proliferation.	FN1 PKD1	3.42e-05	3	118	2	11752017
Pubmed	Epigenomic analysis of gastrulation identifies a unique chromatin state for primed pluripotency.	TET2 KMT2B	3.42e-05	3	118	2	31844322
Pubmed	Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats.	DPP6 SPHKAP	3.42e-05	3	118	2	22479372
Pubmed	Nucleotide binding domain and leucine-rich repeat pyrin domain-containing protein 12: characterization of its binding to hematopoietic cell kinase.	TRAF3IP3 HCK	3.42e-05	3	118	2	32226298
Pubmed	CBFA2T2 and C20orf112: two novel fusion partners of RUNX1 in acute myeloid leukemia.	NOL4L CBFA2T2	3.42e-05	3	118	2	20520637
Pubmed	A novel Cas family member, HEPL, regulates FAK and cell spreading.	CASS4 NEDD9	3.42e-05	3	118	2	18256281
Pubmed	VEGF-PKD1-HDAC7 signaling promotes endothelial progenitor cell migration and tube formation.	HDAC7 PKD1	3.42e-05	3	118	2	24189120
Pubmed	ETO2 coordinates cellular proliferation and differentiation during erythropoiesis.	TCF3 CBFA2T2 BRD1	4.16e-05	20	118	3	16407974
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	NCOA3 POU6F2 TCF3 ETV7 DAXX PPARD SIM1 ZNF446 SP8 CBFA2T2 LHX5 BRD1	4.54e-05	877	118	12	20211142
Pubmed	Cbln1 regulates axon growth and guidance in multiple neural regions.	GLI2 LHX5 ROBO3	5.59e-05	22	118	3	36395107
Pubmed	Tcf/Lef repressors differentially regulate Shh-Gli target gene activation thresholds to generate progenitor patterning in the developing CNS.	TCF3 GLI2 NKX6-1	5.59e-05	22	118	3	21775418
Pubmed	Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis.	FN1 GLI2 NKX6-1	6.42e-05	23	118	3	30814516
Pubmed	Genomic variants in an inbred mouse model predict mania-like behaviors.	CAD OBSCN ZNFX1	6.42e-05	23	118	3	29768498
Pubmed	PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling.	PDPK1 PPARD	6.82e-05	4	118	2	23823620
Pubmed	Mea6 controls VLDL transport through the coordinated regulation of COPII assembly.	CTAGE9 CTAGE8	6.82e-05	4	118	2	27311593
Pubmed	Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).	BRD1 KAT6B	6.82e-05	4	118	2	21880731
Pubmed	Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance.	CTAGE9 CTAGE8	6.82e-05	4	118	2	33718348
Pubmed	Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes.	CTAGE9 CTAGE8	6.82e-05	4	118	2	12586826
Pubmed	Members of the bHLH-PAS family regulate Shh transcription in forebrain regions of the mouse CNS.	SIM1 GLI2	6.82e-05	4	118	2	11023872
Pubmed	MEA6 Deficiency Impairs Cerebellar Development and Motor Performance by Tethering Protein Trafficking.	CTAGE9 CTAGE8	6.82e-05	4	118	2	31244610
Pubmed	Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis.	HDAC7 PKD1	6.82e-05	4	118	2	15738054
Pubmed	Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites.	CTAGE9 CTAGE8	6.82e-05	4	118	2	21807889
Pubmed	Vimentin and Non-Muscle Myosin IIA are Members of the Neural Precursor Cell Expressed Developmentally Down-Regulated 9 (NEDD9) Interactome in Head and Neck Squamous Cell Carcinoma Cells.	MICAL1 NEDD9	6.82e-05	4	118	2	30267961
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TET2 TCF3 DNAJC13 TACC2 PPARD MAP7 GLI2 BRD1 KAT6B	9.28e-05	536	118	9	15840001
Pubmed	The cooperative function of nuclear receptor coactivator 1 (NCOA1) and NCOA3 in placental development and embryo survival.	NCOA3 PDPK1 PPARD	9.35e-05	26	118	3	20685850
Pubmed	Specific and integrated roles of Lmx1a, Lmx1b and Phox2a in ventral midbrain development.	SIM1 LHX5 NKX6-1	9.35e-05	26	118	3	21752929
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 NCOA3 DNAJC13 KMT2B NOL4L SATB1 CEP131 ZNF687	9.42e-05	418	118	8	34709266
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TET2 TCF3 DNAJC13 TACC2 PPARD MAP7 GLI2 BRD1 KAT6B	9.54e-05	538	118	9	10512203
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF13B NCOA3 DNAJC13 CAD SENP3 ZNFX1 KHSRP SEC24C SPHKAP SYN1 CEP131 CEP170B	1.10e-04	963	118	12	28671696
Pubmed	Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation.	HDAC7 PKD1	1.13e-04	5	118	2	15623513
Pubmed	Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase.	PDPK1 SGK3	1.13e-04	5	118	2	10548550
Pubmed	Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2.	TCF3 PKD1	1.13e-04	5	118	2	16311606
Pubmed	PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.	PDPK1 SGK3	1.13e-04	5	118	2	25712345
Pubmed	Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry.	CTAGE9 CTAGE8	1.13e-04	5	118	2	19131326
Pubmed	Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1.	PKD1 FLCN	1.13e-04	5	118	2	36794754
Pubmed	cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.	CTAGE9 CTAGE4	1.13e-04	5	118	2	12839582
Pubmed	STAG2 and Rad21 mammalian mitotic cohesins are implicated in meiosis.	STAG3 STAG2	1.13e-04	5	118	2	12034751
Pubmed	Cross-repressive interaction of the Olig2 and Nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complex.	TCF3 NKX6-1	1.13e-04	5	118	2	14573534
Pubmed	Netrin 1-Mediated Role of the Substantia Nigra Pars Compacta and Ventral Tegmental Area in the Guidance of the Medial Habenular Axons.	GLI2 ROBO3	1.13e-04	5	118	2	34169076
Pubmed	Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis.	CTAGE9 CTAGE8	1.13e-04	5	118	2	18630941
Pubmed	Characterization and expression pattern of the novel MIA homolog TANGO.	CTAGE9 CTAGE8	1.13e-04	5	118	2	15183315
Pubmed	Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development.	CTAGE9 CTAGE8	1.13e-04	5	118	2	38439956
Pubmed	A tissue-specific atlas of mouse protein phosphorylation and expression.	CTAGE9 CTAGE8	1.13e-04	5	118	2	21183079
Pubmed	Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain.	TCF3 NEDD9	1.13e-04	5	118	2	10502414
Pubmed	Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesis.	GLI2 PKD1	1.13e-04	5	118	2	21151991
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	IRF2BP2 TCF3 CBFA2T2	1.45e-04	30	118	3	26593974
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	TCF3 TACC2 PPARD SIM1 SATB1 GLI2 LHX5 KAT6B TOP3A ZNF687	1.57e-04	709	118	10	22988430
Pubmed	Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.	GLI2 SYN1 NKX6-1	1.60e-04	31	118	3	22889265
Pubmed	Heart 6-phosphofructo-2-kinase activation by insulin requires PKB (protein kinase B), but not SGK3 (serum- and glucocorticoid-induced protein kinase 3).	PDPK1 SGK3	1.70e-04	6	118	2	20687898
Pubmed	Bcl-xL dependency coincides with the onset of neurogenesis in the developing mammalian spinal cord.	LHX5 NKX6-1	1.70e-04	6	118	2	27665712
Pubmed	Cryo-EM structure of the human cohesin-NIPBL-DNA complex.	STAG3 STAG2	1.70e-04	6	118	2	32409525
Pubmed	Tace/ADAM17 is a bi-directional regulator of axon guidance that coordinates distinct Frazzled and Dcc receptor signaling outputs.	LHX5 ROBO3	1.70e-04	6	118	2	36476876
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	IRF2BP2 NCOA3 SATB1 STAG2	1.88e-04	83	118	4	28794006
Pubmed	Functional proteomics mapping of a human signaling pathway.	PNPLA2 KMT2B FN1 SENP3 PPARD NEDD9 PKD1 BRD1 SDK1	1.93e-04	591	118	9	15231748
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	KMT2B WNK1 KHSRP SGK3 ADAMTS12 KCNH6 TTBK1 B3GNT2 KAT6B HCK	1.99e-04	730	118	10	34857952
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	NCOA3 TCF3 RBM33 PDPK1 DAXX ZNFX1 ATG2A WNK1 RIC8B SEC24C PIK3C2B GPSM1	2.20e-04	1038	118	12	26673895
Pubmed	MICAL, a novel CasL interacting molecule, associates with vimentin.	MICAL1 NEDD9	2.37e-04	7	118	2	11827972
Pubmed	Transcriptional repression of atherogenic inflammation: modulation by PPARdelta.	PPARD HDAC7	2.37e-04	7	118	2	12970571
Pubmed	Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells.	NEDD9 HCK	2.37e-04	7	118	2	9020138
Pubmed	Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.	BRD1 KAT6B	2.37e-04	7	118	2	18794358
Pubmed	A high-resolution linkage map of the tight skin 2 (Tsk2) locus: a mouse model for scleroderma (SSc) and other cutaneous fibrotic diseases.	FN1 SGK3	2.37e-04	7	118	2	8678985
Pubmed	cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice.	CTAGE9 CTAGE8	2.37e-04	7	118	2	29133483
Pubmed	Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.	TCF3 CBFA2T2	2.37e-04	7	118	2	19799863
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	FAM193B KMT2B WNK1 AFAP1L2 CBFA2T2 HSFX1 CACNA1G ZNF488 KAT6B	2.37e-04	608	118	9	16713569
Pubmed	Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.	MICAL1 CTC1 ATG2A DCAF5 TTBK1 SPHKAP	2.54e-04	257	118	6	30945288
Pubmed	A census of human transcription factors: function, expression and evolution.	NCOA3 POU6F2 TCF3 ETV7 ZNFX1 PPARD TOE1 SATB1 GLI2 LHX5 NKX6-1	2.74e-04	908	118	11	19274049
Pubmed	The DNA sequence and analysis of human chromosome 6.	MICAL1 ETV7 DAXX PPARD SIM1 MAP7 TTBK1 AARS2 KIF25	2.81e-04	622	118	9	14574404
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	KIF13B POU6F2 AFAP1L2 GLI2 PKD1	3.03e-04	171	118	5	20201926
Pubmed	A V0 core neuronal circuit for inspiration.	SIM1 ROBO3	3.15e-04	8	118	2	28916788
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	KIF13B FN1 CTC1 OBSCN TACC2 WNK1 SHROOM2 WDFY4 DCAF5 NOL4L SEC24C STAG2	3.26e-04	1084	118	12	11544199
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NCOA3 CAD TACC2 MAP7 WNK1 KHSRP CEP131 ZNF687	3.30e-04	503	118	8	16964243
Pubmed	Phox2a Defines a Developmental Origin of the Anterolateral System in Mice and Humans.	POU6F2 NKX6-1 ROBO3	3.43e-04	40	118	3	33238113
Pubmed	Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.	NCOA3 DAXX GLI2	3.43e-04	40	118	3	28805822
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	DPP6 MICAL1 IL16 DNAJC13 CAD FN1 ZNFX1 MAP7 SHROOM2 KHSRP SEC24C SYN1 HCK CEP170B	3.60e-04	1431	118	14	37142655
Pubmed	Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.	WNK1 SATB1 KAT6B	3.69e-04	41	118	3	15561718
Pubmed	Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.	TCF3 KHSRP SEC24C PIK3C2B B3GNT2 HCK	3.71e-04	276	118	6	28319085
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TET2 IRF2BP2 NCOA3 TCF3 CAD KMT2B RBM33 BICRA KHSRP NOL4L STAG2 ZNF687	3.81e-04	1103	118	12	34189442
Pubmed	PDPK1 regulates autophagosome biogenesis by binding to PIK3C3.	PDPK1 SENP3	4.05e-04	9	118	2	32876514
Pubmed	Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.	CTAGE9 CTAGE8	4.05e-04	9	118	2	18342301
Interaction	CTAGE1 interactions	CTAGE6 CTAGE8 CTAGE15 CTAGE4	1.92e-07	10	113	4	int:CTAGE1
Cytoband	7q35	CTAGE6 CTAGE8 CTAGE15 CTAGE4	1.28e-05	55	118	4	7q35
Cytoband	Ensembl 112 genes in cytogenetic band chr7q35	CTAGE6 CTAGE8 CTAGE15 CTAGE4	2.64e-05	66	118	4	chr7q35
GeneFamily	CTAGE family	CTAGE9 CTAGE6 CTAGE8 CTAGE15 CTAGE4	3.34e-09	15	76	5	907
GeneFamily	Cas scaffolding proteins	CASS4 NEDD9	1.04e-04	4	76	2	469
GeneFamily	Cohesin complex	STAG3 STAG2	4.80e-04	8	76	2	1060
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA3 KAT6B	2.28e-03	17	76	2	486
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS3 ADAMTS12	2.85e-03	19	76	2	50
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CASS4 IL16 FN1 ADAMTS12 GLI2 GPSM1 SDK1	7.98e-07	193	117	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CASS4 IL16 EOGT ADAMTS12 GLI2 GPSM1 SDK1	7.98e-07	193	117	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	CASS4 IL16 FN1 ADAMTS12 GLI2 GPSM1 SDK1	8.55e-07	195	117	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	facs-Heart-RA-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL16 SFTPB WDFY4 SATB1 PIP5KL1 TRAF3IP3	6.51e-06	173	117	6	49030c2dd04b592655df1a667e2f90efb499e0a5
ToppCell	facs-Heart-RA-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL16 SFTPB WDFY4 SATB1 PIP5KL1 TRAF3IP3	6.51e-06	173	117	6	1cfbab6603f8baf8e238837bb72740c43a7dc0ec
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-cDC2\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CASS4 XIRP1 IL16 WDFY4 TRAF3IP3 HCK	9.55e-06	185	117	6	e592c27f711d13bfc6546893acaab4c8600b0be1
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	CASS4 FN1 ADAMTS12 GLI2 GPSM1 SDK1	1.21e-05	193	117	6	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CASS4 IL16 EOGT ADAMTS12 GPSM1 SDK1	1.25e-05	194	117	6	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	IL16 EOGT FN1 ADAMTS12 GPSM1 SDK1	1.29e-05	195	117	6	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	IL16 FN1 ADAMTS12 GLI2 GPSM1 SDK1	1.40e-05	198	117	6	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Transverse-(5)_Dendritic_cell-(51)_cDC1\|Transverse / shred on region, Cell_type, and subtype	TET2 CTAGE9 RAB31 WDFY4 ZNF469 HCK	1.44e-05	199	117	6	52dd1c4cd372f8ee515307a9200e357bb2145888
ToppCell	Transverse-Dendritic_cell-cDC1\|Transverse / Region, Cell class and subclass	TET2 CTAGE9 RAB31 WDFY4 ZNF469 HCK	1.44e-05	199	117	6	b68419939d206417158a703f60a374bf8ec5d5a1
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CASS4 IL16 FN1 ADAMTS12 GLI2 SDK1	1.49e-05	200	117	6	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CASS4 IL16 FN1 ADAMTS12 GLI2 SDK1	1.49e-05	200	117	6	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CASS4 IL16 FN1 ADAMTS12 GPSM1 SDK1	1.49e-05	200	117	6	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Globus_pallidus\|World / BrainAtlas - Mouse McCarroll V32	MIIP FAM193B SIM1 HDAC7 PKD1	2.07e-05	126	117	5	44b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM193B ADAMTS12 PEX16 STAG3 TMUB2	3.68e-05	142	117	5	67d4ff3483ae34f77c3325aa0fbd3462ca19ade4
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFTPB SIM1 GLI2 SPHKAP OCSTAMP	4.48e-05	148	117	5	dfd3f2c4b884ea9e23831a242a89ac985b409640
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFAP47 KIF13B BICRA WDFY4 TOP3A	6.89e-05	162	117	5	388670cf3acef17df971c0d8ae3ce14398945192
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS3 CTAGE6 WNK1 AFAP1L2 SDK1	6.89e-05	162	117	5	285e6d553f485fd9f1075c4e1b940da251b5ea35
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFAP47 KIF13B BICRA WDFY4 TOP3A	6.89e-05	162	117	5	9333d923225df7bfdf6b3a4c32816751315aec50
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KMT2B ATG2A PLEKHD1 WDFY4 ZNF469	7.73e-05	166	117	5	c8a7d94ed762e5e045ab5f74eef691ddc5f74993
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	OBSCN ARHGAP17 FAM156A SPHKAP BRD1	7.95e-05	167	117	5	e488d9c7cf4355959e3833de3bd496c13fc11b1b
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ADAMTS3 PLEKHD1 MARK4 PIP5KL1 LHX5	7.95e-05	167	117	5	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ADAMTS3 PLEKHD1 MARK4 PIP5KL1 LHX5	7.95e-05	167	117	5	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	OBSCN QRICH2 CASKIN2 KDM8 STAG3	8.89e-05	171	117	5	1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 ARPP21 B3GNT2 ROBO3 CEP170B	1.02e-04	176	117	5	29cda51a99100ddd2928cadc92da40f001d7e1f4
ToppCell	facs-Trachea-24m-Hematologic-lymphocytic-B_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCF3 WDFY4 SATB1 PIK3C2B HCK	1.02e-04	176	117	5	318dc722b95e269002fb01a0feb91c0c8539e150
ToppCell	facs-Trachea-24m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCF3 WDFY4 SATB1 PIK3C2B HCK	1.02e-04	176	117	5	f6891006d816309edabe75b2abf60675f2958e55
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 ARPP21 B3GNT2 ROBO3 CEP170B	1.02e-04	176	117	5	01774a86d7d92f31a056b753f9844f923038003e
ToppCell	metastatic_Brain-Myeloid_cells-CD141+_DCs\|metastatic_Brain / Location, Cell class and cell subclass	CEACAM3 WDFY4 SPHKAP ROBO3 HCK	1.02e-04	176	117	5	b9ba7026dee2272c0b483dc0cfa39f74b75f1634
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	KIF13B NCOA3 DNAJC13 UTY CEP170B	1.05e-04	177	117	5	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CASS4 RAB31 CEACAM3 WDFY4 HCK	1.05e-04	177	117	5	345cebc19f93970a9a46be139208b300081f5493
ToppCell	cellseq2-Immune-Immune_Myeloid-AM\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RAB31 FN1 WDFY4 HCK OCSTAMP	1.16e-04	181	117	5	d4ab8ab41bf3e6f1937e919662456d7c9551eeab
ToppCell	(2)_5-FU-(4)_COL2.3+_osteoblasts\|(2)_5-FU / Stress and Cell class	FN1 SATB1 CLEC11A PKD1 CEP170B	1.16e-04	181	117	5	56ae86072858c156681507aecd1bc6cb0a3372d2
ToppCell	cellseq2-Immune-Immune_Myeloid-AM-AM\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RAB31 FN1 WDFY4 HCK OCSTAMP	1.16e-04	181	117	5	45fc9c27ea60312a118a2a6c1eb635d776fde295
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-cDC1\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CASS4 RAB31 CEACAM3 WDFY4 HCK	1.22e-04	183	117	5	8542040b7585842b89bb1329dae4029c1b7b5427
ToppCell	Immune_cells-large_pre-B.\|World / Lineage and Cell class	TCF3 IL16 ARPP21 WDFY4 NEDD9	1.22e-04	183	117	5	81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e
ToppCell	COPD-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	TET2 RAB31 PPARD SYN1 HCK	1.25e-04	184	117	5	ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RAB31 CEACAM3 WDFY4 NKX6-1 HCK	1.25e-04	184	117	5	4f4aeef3b821a003e857fe4a195124d44b2d7479
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CASS4 RAB31 WDFY4 NEDD9 HCK	1.32e-04	186	117	5	305f1726b8b5add32f1c29c74991ff34f42e0da7
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CASS4 IL16 RAB31 WDFY4 HCK	1.32e-04	186	117	5	5916ee851c17d6d9adefeea900b4dfa9642982dc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CASS4 RAB31 WDFY4 TRAF3IP3 HCK	1.32e-04	186	117	5	e152bdd837366e3e0b8bcfdb4d53f0685f2e803a
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	DPP6 IL16 FN1 ADAMTS12 SDK1	1.35e-04	187	117	5	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	CASS4 FN1 ADAMTS12 GPSM1 SDK1	1.35e-04	187	117	5	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	wk_08-11-Hematologic-Myeloid-DC1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	IL16 CEACAM3 WDFY4 TRAF3IP3 HCK	1.35e-04	187	117	5	2907cc0b8789c5e1468917caa21fa0feb025305e
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	NCOA3 RAB31 ADAMTS12 ZNF469 CBFA2T2	1.39e-04	188	117	5	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DPP6 POU6F2 MAP7 HDAC7 SDK1	1.39e-04	188	117	5	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	COPD-Myeloid-cMonocyte\|COPD / Disease state, Lineage and Cell class	TET2 RAB31 PPARD SYN1 HCK	1.42e-04	189	117	5	d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPP21 HDAC7 SATB1 ZNF488 TRAF3IP3	1.46e-04	190	117	5	2f5460fa028dfe6b80dd024063a4513dc532a94d
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	IL16 FN1 ADAMTS12 GLI2 SDK1	1.46e-04	190	117	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	ILEUM-non-inflamed-(8)_Activated_fibroblasts\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAP7 ZNF446 ADAMTS12 GPSM1 TOP3A	1.46e-04	190	117	5	39fa110d19c97c7cac99f5fb91b26bc08e2f3b42
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B TACC2 MAP7 NOL4L SDK1	1.49e-04	191	117	5	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CASS4 RAB31 WDFY4 TRAF3IP3 HCK	1.49e-04	191	117	5	c72e62cf5b45c04ee5e7719db31f917c4f76b1e4
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 ARHGAP17 NEDD9 PIK3C2B HCK	1.53e-04	192	117	5	2de242d81dc085ae734eb7d1f091af9a542e0866
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	RBM33 WNK1 NEDD9 CBFA2T2 SDK1	1.53e-04	192	117	5	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 ARHGAP17 NEDD9 PIK3C2B HCK	1.53e-04	192	117	5	ba2a683472a8b785dbf666dc6e94356d879486c3
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	CASS4 FN1 ADAMTS12 GLI2 SDK1	1.57e-04	193	117	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	facs-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 ARPP21 HDAC7 SATB1 UTY	1.60e-04	194	117	5	f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CASS4 FN1 ADAMTS12 GLI2 SDK1	1.60e-04	194	117	5	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	facs-Thymus-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 ARPP21 HDAC7 SATB1 UTY	1.60e-04	194	117	5	cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CASS4 RAB31 WDFY4 TRAF3IP3 HCK	1.60e-04	194	117	5	0866ab6792cee274a71991d5c37a37f574ff446e
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CASS4 FN1 ADAMTS12 GLI2 SDK1	1.60e-04	194	117	5	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	facs-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 ARPP21 HDAC7 SATB1 UTY	1.60e-04	194	117	5	66c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 ARHGAP17 NEDD9 PIK3C2B HCK	1.64e-04	195	117	5	d77423d0ec64b397c6d1eec181c5fc0acaa92d63
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 SATB1 SPHKAP NKX6-1 UTY	1.64e-04	195	117	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 ARHGAP17 NEDD9 PIK3C2B HCK	1.64e-04	195	117	5	f5bf4797972185afa76638293166abd536e5472f
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)\|Adult / Lineage, Cell type, age group and donor	RAB31 PPARD WDFY4 SGK3 HCK	1.64e-04	195	117	5	55e25f702af19146a161861cfd15f40bbda1dc35
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 SATB1 SPHKAP NKX6-1 UTY	1.64e-04	195	117	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CASS4 CEACAM3 WDFY4 SATB1 HCK	1.68e-04	196	117	5	b71d711be5609115b00a57700885aca608920896
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IL16 FN1 ADAMTS12 GLI2 SDK1	1.68e-04	196	117	5	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RAB31 PPARD TTBK1 SATB1 HCK	1.72e-04	197	117	5	e2983ae16c72371fbf0e5c123de9f4d900724e5e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CASS4 XIRP1 ZNFX1 NEDD9 SEC24C	1.72e-04	197	117	5	b597c292fc1cb381a4325fed15a32966c38def28
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-G\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	CASS4 DPP6 FN1 SFTPB NEDD9	1.72e-04	197	117	5	a21a710c824f9e5c7ef1674168d1ce5aef85bd35
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CASS4 KIF13B IL16 FN1 ADAMTS12	1.72e-04	197	117	5	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IL16 FN1 ADAMTS12 GLI2 SDK1	1.76e-04	198	117	5	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 RAB31 CEACAM3 WDFY4 HCK	1.81e-04	199	117	5	5abfbccae147d399e4234f90ae5cd9529abe4dd1
ToppCell	Control_saline-Hematopoietic_Lymphocytic-B_cells\|Control_saline / Treatment groups by lineage, cell group, cell type	IL16 ARPP21 WDFY4 TRAF3IP3 HCK	1.81e-04	199	117	5	a984b83d6e143c1e497726da09d8e1acf1f59a74
ToppCell	Control_saline-Hematopoietic_Lymphocytic-B_cells-B-cells\|Control_saline / Treatment groups by lineage, cell group, cell type	IL16 ARPP21 WDFY4 TRAF3IP3 HCK	1.81e-04	199	117	5	8913a2f255f42a684221fa0c812e254aa43d8704
ToppCell	Severe-B_intermediate-6\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TET2 RAB31 ARHGAP17 WDFY4 HCK	1.81e-04	199	117	5	bf6ebb63ab361d9d1946225894d7be433e9befab
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 FN1 TSPYL5 ITIH6 GPSM1	1.85e-04	200	117	5	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 FN1 ADAMTS12 GLI2 SDK1	1.85e-04	200	117	5	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CASS4 IL16 FN1 ADAMTS12 SDK1	1.85e-04	200	117	5	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 FN1 TSPYL5 ITIH6 GPSM1	1.85e-04	200	117	5	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 FN1 TSPYL5 ITIH6 GPSM1	1.85e-04	200	117	5	b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 FN1 ADAMTS12 GLI2 SDK1	1.85e-04	200	117	5	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Glia_progenitor_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	DNAJC13 RAB31 PLEKHD1 ADAMTS12 ZNF488	1.85e-04	200	117	5	6c1b7b0f3cd35d8cfee181ea83c73127dbc41ac5
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IL16 FN1 TSPYL5 ITIH6 GPSM1	1.85e-04	200	117	5	7c673ad0ea503ebd196579684d25d5f9e6a41030
Drug	Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A	MICAL1 PNPLA2 CEACAM3 HDAC7 ZNF446 ADAMTS12 CLEC11A KDM8 UTY	6.49e-07	198	113	9	2797_UP
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	MICAL1 PNPLA2 TCF3 BICRA PPARD NEDD9 CLCA2 GLI2 MARK4	7.06e-07	200	113	9	7156_UP
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A	SFTPB HDAC7 KHSRP ADAMTS12 CASKIN2 B3GNT2 UTY TOP3A	6.18e-06	196	113	8	3724_DN
Drug	Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A	CASS4 RAB31 SFTPB PPARD KHSRP CASKIN2 MARK4 CEP170B	6.18e-06	196	113	8	6744_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A	MIIP NCOA3 PNPLA2 PPARD CBFA2T2 B3GNT2 KDM8 TOP3A	6.66e-06	198	113	8	3756_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; MCF7; HT_HG-U133A	MIIP KMT2B ATG2A NEDD9 KAT6B STAG3 CEP170B TOP3A	6.91e-06	199	113	8	5346_DN
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A	EOGT RAB31 ADAMTS3 BICRA PPARD CEP131 TOP3A	5.11e-05	193	113	7	1805_DN
Drug	Clotrimazole [23593-75-1]; Down 200; 11.6uM; HL60; HG-U133A	RAB31 SENP3 WNK1 NEDD9 FAM222B MARK4 TRAF3IP3	5.11e-05	193	113	7	1549_DN
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MIIP MICAL1 PNPLA2 SFTPB PPARD HDAC7 KDM8	5.11e-05	193	113	7	3627_DN
Drug	Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A	MIIP MICAL1 BICRA MAP7 ZNF446 NEDD9 CBFA2T2	5.11e-05	193	113	7	6209_UP
Drug	Syrosingopine [84-36-6]; Down 200; 6uM; MCF7; HT_HG-U133A	WNK1 TOE1 RIC8B COA1 UTY TMUB2 TOP3A	5.28e-05	194	113	7	2753_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	NCOA3 RAB31 PPARD HDAC7 MARK4 ROBO3 STAG3	5.28e-05	194	113	7	1814_DN
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A	SFTPB PDPK1 PPARD KHSRP ADAMTS12 CLEC11A TOP3A	5.45e-05	195	113	7	3737_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	MIIP NCOA3 CTC1 MAP7 MARK4 UTY TOP3A	5.45e-05	195	113	7	7309_UP
Drug	Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A	POU6F2 RAB31 KMT2B CTC1 CASKIN2 CLEC11A CEP131	5.45e-05	195	113	7	7372_UP
Drug	Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	IL16 SFTPB CEACAM3 KCNH6 CLCA2 CLEC11A CACNA1G	5.45e-05	195	113	7	3800_UP
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A	MIIP TCF3 RAB31 SENP3 MARK4 KAT6B TMUB2	5.63e-05	196	113	7	1794_DN
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; HL60; HT_HG-U133A	PNPLA2 SFTPB WNK1 NEDD9 MARK4 CEP170B TOP3A	5.63e-05	196	113	7	2335_UP
Drug	Enoxacin [74011-58-8]; Down 200; 12.4uM; HL60; HG-U133A	PNPLA2 PDPK1 SENP3 ATG2A CLEC11A CEP170B TOP3A	5.63e-05	196	113	7	1597_DN
Drug	Azapropazone [13539-59-8]; Down 200; 13.4uM; PC3; HT_HG-U133A	RAB31 SFTPB COA1 PEX16 CEP131 UTY TOP3A	5.63e-05	196	113	7	7277_DN
Drug	Midecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A	MIIP PNPLA2 FN1 SFTPB CASKIN2 UTY TOP3A	5.63e-05	196	113	7	5345_UP
Drug	Cromolyn disodium salt [15826-37-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A	MICAL1 SFTPB WNK1 HDAC7 CASKIN2 CBFA2T2 TOP3A	5.63e-05	196	113	7	3475_UP
Drug	Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A	MIIP TCF3 CTC1 HDAC7 KHSRP FAM222B UTY	5.81e-05	197	113	7	5785_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A	MICAL1 PNPLA2 TCF3 FN1 SFTPB CEACAM3 KAT6B	5.81e-05	197	113	7	6241_UP
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A	CASS4 KIF13B SFTPB PPARD KCNH6 MARK4 KIF25	5.81e-05	197	113	7	3925_UP
Drug	(+,-)-Synephrine [94-07-5]; Up 200; 24uM; PC3; HT_HG-U133A	SFTPB CTC1 HDAC7 CLEC11A CBFA2T2 CACNA1G KDM8	5.81e-05	197	113	7	7150_UP
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	CLCA2 CBFA2T2 MARK4 COA1 KDM8 ROBO3 STAG3	5.81e-05	197	113	7	5643_DN
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; PC3; HT_HG-U133A	MIIP MICAL1 PNPLA2 CEACAM3 KHSRP KDM8 UTY	5.81e-05	197	113	7	4017_DN
Drug	Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A	KIF13B FN1 SFTPB ZNF446 KHSRP FLCN ROBO3	5.81e-05	197	113	7	3820_DN
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	TCF3 SFTPB WNK1 MARK4 KDM8 ROBO3 STAG3	5.81e-05	197	113	7	2218_DN
Drug	Hydroflumethiazide [135-09-1]; Down 200; 12uM; PC3; HT_HG-U133A	RAB31 SFTPB PPARD MAP7 HDAC7 MARK4 STAG3	5.81e-05	197	113	7	1809_DN
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	FN1 CEACAM3 KHSRP NEDD9 KDM8 STAG3 KIF25	5.81e-05	197	113	7	6271_UP
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; PC3; HT_HG-U133A	MICAL1 RAB31 CEACAM3 HDAC7 ZNF446 KDM8 STAG3	5.81e-05	197	113	7	4674_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A	TCF3 WNK1 HDAC7 NEDD9 SATB1 STAG2 KIF25	6.00e-05	198	113	7	5422_UP
Drug	Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; PC3; HT_HG-U133A	MIIP KMT2B CTC1 PPARD ZNF446 FAM222B MARK4	6.00e-05	198	113	7	4595_DN
Drug	Aconitine [302-27-2]; Down 200; 6.2uM; HL60; HG-U133A	NCOA3 MICAL1 TCF3 FN1 FAM222B TRAF3IP3 BRD1	6.00e-05	198	113	7	1784_DN
Drug	Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A	MIIP NCOA3 TCF3 PPARD MAP7 FLCN ROBO3	6.00e-05	198	113	7	6560_UP
Drug	Iocetamic acid [16034-77-8]; Down 200; 6.6uM; PC3; HT_HG-U133A	MIIP RAB31 KMT2B CTC1 PPARD ZNF446 CBFA2T2	6.00e-05	198	113	7	4600_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	TCF3 RAB31 KMT2B SFTPB WNK1 HDAC7 FLCN	6.00e-05	198	113	7	4592_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	FN1 CEACAM3 KHSRP MARK4 PEX16 CEP131 KDM8	6.00e-05	198	113	7	4133_DN
Drug	PF-01378883-00 [351320-41-7]; Down 200; 10uM; PC3; HT_HG-U133A	IL16 FN1 PPARD HDAC7 CLEC11A CBFA2T2 TOP3A	6.20e-05	199	113	7	6410_DN
Drug	3-nitropropionic acid; Up 200; 10uM; PC3; HT_HG-U133A	TCF3 BICRA PPARD ZNF446 CLEC11A UTY STAG3	6.20e-05	199	113	7	6407_UP
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; PC3; HT_HG-U133A	MIIP TCF3 FN1 PPARD HDAC7 GLI2 ROBO3	6.20e-05	199	113	7	2095_UP
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	MIIP MICAL1 PNPLA2 HDAC7 KHSRP CLEC11A CBFA2T2	6.20e-05	199	113	7	3860_DN
Drug	Carbamazepine [298-46-4]; Up 200; 17uM; HL60; HT_HG-U133A	MIIP FN1 MAP7 HDAC7 KHSRP UTY TOP3A	6.20e-05	199	113	7	1847_UP
Drug	Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A	RAB31 FN1 CEACAM3 PPARD SHROOM2 CASKIN2 GLI2	6.20e-05	199	113	7	7367_UP
Drug	Torsemide [56211-40-6]; Down 200; 11.4uM; PC3; HT_HG-U133A	KIF13B PNPLA2 RAB31 SFTPB ZNF446 CBFA2T2 UTY	6.20e-05	199	113	7	5057_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	MIIP KIF13B PDPK1 CASKIN2 UTY TMUB2 CEP170B	6.39e-05	200	113	7	2838_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	FN1 ETV7 PPARD HDAC7 ADAMTS12 CLEC11A NKX6-1	6.39e-05	200	113	7	5570_UP
Drug	Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; PC3; HT_HG-U133A	MIIP TCF3 FN1 CTC1 CASKIN2 STAG3 TOP3A	6.39e-05	200	113	7	5772_DN
Drug	N,N-Dibenzylethanolamine	WNK1 PEX16	1.46e-04	4	113	2	CID000022656
Drug	Indium	FN1 CEACAM3 CEP131 KAT6B	2.12e-04	59	113	4	CID000105148
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	RAB31 PDPK1 PPARD SHROOM2 NEDD9 MARK4	2.66e-04	178	113	6	5065_UP
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	SFTPB CTC1 PPARD MAP7 KDM8 CEP170B	2.90e-04	181	113	6	1236_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	PNPLA2 RAB31 SHROOM2 NEDD9 MARK4 PEX16	2.99e-04	182	113	6	6316_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	KIF13B FN1 PPARD NEDD9 CBFA2T2 MARK4	3.36e-04	186	113	6	6891_UP
Drug	Salbutamol [18559-94-9]; Up 200; 16.8uM; HL60; HT_HG-U133A	KIF13B NCOA3 RAB31 FN1 MARK4 TRAF3IP3	3.46e-04	187	113	6	2344_UP
Drug	Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A	PNPLA2 SFTPB MARK4 COA1 PEX16 TOP3A	3.56e-04	188	113	6	5490_UP
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A	TACC2 PPARD MAP7 MARK4 ROBO3 STAG3	3.56e-04	188	113	6	7104_UP
Drug	Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A	MICAL1 PNPLA2 IL16 FN1 CEACAM3 PPARD	3.87e-04	191	113	6	6028_UP
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	SFTPB WNK1 CASKIN2 MARK4 FLCN KAT6B	3.87e-04	191	113	6	6644_DN
Drug	Iodipamide [606-17-7]; Down 200; 3.6uM; PC3; HT_HG-U133A	PPARD MAP7 ZNF446 CBFA2T2 FLCN UTY	3.87e-04	191	113	6	5085_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	TCF3 SFTPB BICRA CLEC11A CEP131 ROBO3	3.98e-04	192	113	6	2699_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A	NCOA3 WNK1 TRAF3IP3 KAT6B UTY TOP3A	4.09e-04	193	113	6	2477_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	PNPLA2 ZNF446 CLEC11A MARK4 COA1 TOP3A	4.09e-04	193	113	6	5629_DN
Drug	Isotretinoin [4759-48-2]; Up 200; 13.4uM; PC3; HT_HG-U133A	PNPLA2 SFTPB CEACAM3 UTY TOP3A KIF25	4.09e-04	193	113	6	7315_UP
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	MIIP POU6F2 TCF3 SFTPB CASKIN2 UTY	4.09e-04	193	113	6	2078_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	KIF13B FN1 ATG2A ZNF446 UTY TMUB2	4.20e-04	194	113	6	7001_UP
Drug	Corticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A	PNPLA2 ATG2A WNK1 CLEC11A FLCN CEP131	4.20e-04	194	113	6	1307_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	PNPLA2 TCF3 KMT2B NEDD9 CASKIN2 CEP131	4.20e-04	194	113	6	7214_DN
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A	WNK1 ZNF446 CLEC11A CBFA2T2 MARK4 TOP3A	4.20e-04	194	113	6	5450_DN
Drug	Skimmianine [83-95-4]; Up 200; 15.4uM; HL60; HT_HG-U133A	POU6F2 ARPP21 GLI2 CBFA2T2 PEX16 TSPYL5	4.20e-04	194	113	6	2504_UP
Drug	Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A	MICAL1 WNK1 CASKIN2 MARK4 COA1 UTY	4.20e-04	194	113	6	2792_DN
Drug	Imipenem [74431-23-5]; Down 200; 13.4uM; HL60; HG-U133A	MIIP NCOA3 IL16 PIK3C2B PEX16 CEP170B	4.20e-04	194	113	6	1724_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	MIIP MICAL1 PNPLA2 WNK1 CBFA2T2 FLCN	4.20e-04	194	113	6	3859_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A	MIIP PNPLA2 FN1 SENP3 CEACAM3 CEP170B	4.20e-04	194	113	6	1422_UP
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A	PNPLA2 TCF3 CASKIN2 KDM8 STAG3 TOP3A	4.20e-04	194	113	6	2221_DN
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	CTC1 ZNF446 ADAMTS12 CASKIN2 CBFA2T2 MARK4	4.20e-04	194	113	6	4951_UP
Drug	CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A	PNPLA2 KMT2B BICRA PPARD CBFA2T2 STAG3	4.20e-04	194	113	6	6417_DN
Drug	splitomicin; Up 200; 20uM; PC3; HG-U133A	RAB31 ETV7 ADAMTS12 CASKIN2 MARK4 UTY	4.20e-04	194	113	6	661_UP
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A	MIIP TCF3 FN1 SFTPB PPARD KDM8	4.20e-04	194	113	6	2520_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; PC3; HT_HG-U133A	TCF3 PPARD KHSRP CLCA2 CBFA2T2 TRAF3IP3	4.20e-04	194	113	6	4537_UP
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; HL60; HT_HG-U133A	NCOA3 KMT2B FN1 HDAC7 NEDD9 ROBO3	4.20e-04	194	113	6	2377_UP
Drug	Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A	SENP3 MAP7 FAM222B B3GNT2 MARK4 COA1	4.20e-04	194	113	6	4602_DN
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A	MIIP FN1 FAM222B MARK4 STAG3 TOP3A	4.32e-04	195	113	6	5313_UP
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	MIIP CASS4 CLCA2 MARK4 COA1 PEX16	4.32e-04	195	113	6	5024_UP
Drug	radicicol; Up 200; 0.1uM; PC3; HT_HG-U133A	CTC1 PPARD ZNF446 GLI2 KDM8 STAG3	4.32e-04	195	113	6	5952_UP
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	MIIP MICAL1 TCF3 KAT6B STAG3 TMUB2	4.32e-04	195	113	6	1700_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; HL60; HT_HG-U133A	CASS4 KHSRP KCNH6 CASKIN2 GLI2 CACNA1G	4.32e-04	195	113	6	2544_UP
Drug	Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A	IL16 FN1 SFTPB BICRA WNK1 KAT6B	4.32e-04	195	113	6	2956_DN
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A	MIIP MICAL1 RAB31 SFTPB PPARD CBFA2T2	4.32e-04	195	113	6	4597_DN
Drug	Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; HL60; HG-U133A	NCOA3 BICRA KHSRP PIK3C2B CLEC11A HCK	4.32e-04	195	113	6	1966_UP
Drug	Tamoxifen citrate [54965-24-1]; Down 200; 7uM; PC3; HT_HG-U133A	SENP3 TACC2 MAP7 FAM222B CEP131 KAT6B	4.32e-04	195	113	6	2050_DN
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; PC3; HT_HG-U133A	FN1 PPARD WNK1 CLEC11A CBFA2T2 KIF25	4.32e-04	195	113	6	3991_UP
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A	TCF3 KMT2B BICRA CASKIN2 CLEC11A STAG3	4.32e-04	195	113	6	3408_DN
Drug	Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A	PNPLA2 HDAC7 ZNF446 MARK4 FLCN KIF25	4.32e-04	195	113	6	3321_UP
Drug	Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	PNPLA2 TCF3 SFTPB BICRA CLEC11A CBFA2T2	4.32e-04	195	113	6	6770_DN
Drug	troglitazone; Up 200; 10uM; PC3; HG-U133A	MIIP DPP6 ADAMTS3 BICRA PPARD FAM222B	4.32e-04	195	113	6	431_UP
Drug	Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; PC3; HT_HG-U133A	MIIP KIF13B CTC1 BICRA MAP7 SHROOM2	4.32e-04	195	113	6	4229_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	FN1 PPARD ADAMTS12 CLCA2 CBFA2T2 ROBO3	4.32e-04	195	113	6	5582_UP
Disease	Malignant neoplasm of breast	NCOA3 MICAL1 XIRP1 FN1 PDPK1 OBSCN TACC2 SIM1 WNK1 SHROOM2 PLEKHD1 HDAC7 SGK3 CLCA2 KAT6B	9.81e-06	1074	109	15	C0006142
Disease	Cyst	PKD1 FLCN	1.35e-05	2	109	2	C0010709
Disease	Connective Tissue Diseases	ZNF469 PKD1 FLCN	1.37e-05	13	109	3	C0009782
Disease	Acute Promyelocytic Leukemia	TET2 IRF2BP2 GLI2	6.63e-04	46	109	3	C0023487
Disease	Dupuytren Contracture	POU6F2 RAB31 TACC2 SDK1	7.03e-04	108	109	4	EFO_0004229
Disease	mean reticulocyte volume	CAD HDAC7 ZNF469 NOL4L B3GNT2 MARK4 FLCN TRAF3IP3 STAG2 TMUB2	7.66e-04	799	109	10	EFO_0010701
Disease	Colorectal Carcinoma	TET2 TCF3 CAD FN1 OBSCN WNK1 CYREN FLCN TRAF3IP3	1.20e-03	702	109	9	C0009402
Disease	waist-hip ratio	TET2 PNPLA2 ARPP21 FN1 SIM1 WNK1 ZNF446 NEDD9 SP8 RIC8B PIK3C2B PKD1	1.92e-03	1226	109	12	EFO_0004343
Disease	MYELODYSPLASTIC SYNDROME	TET2 CTC1 STAG2	1.98e-03	67	109	3	C3463824
Disease	visceral adipose tissue measurement	ARPP21 DAXX WNK1 SEC24C PIK3C2B SPHKAP PKD1	2.09e-03	481	109	7	EFO_0004765
Disease	peak expiratory flow	TET2 MICAL1 PPARD PIK3C2B PKD1 NKX6-1 BRD1	2.54e-03	498	109	7	EFO_0009718
Disease	HIV-1 infection, Susceptibility to viral and mycobacterial infections	BICRA NEDD9	2.71e-03	21	109	2	EFO_0000180, Orphanet_391311
Disease	prostate cancer (is_marker_for)	NCOA3 TCF3 KMT2B DAXX	2.72e-03	156	109	4	DOID:10283 (is_marker_for)
Disease	electrocardiography	OBSCN ZNFX1 SGK3 SP8 CACNA1G KAT6B HCK	3.58e-03	530	109	7	EFO_0004327

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSGQNEAPPNTHSIP	EOGT	16	Q5NDL2
SQQHSQPLPTGPGLE	BRD1	756	O95696
LHPPDSQASGQGVPL	CASS4	206	Q9NQ75
QTDPTGPEGPHLGQS	CTC1	716	Q2NKJ3
PSSPGNPLDHQITNE	CTAGE4	561	Q8IX94
PRGPGNPLDHQITNE	CTAGE6	561	Q86UF2
PSSPGNPLDHQITNE	CTAGE8	561	P0CG41
PSSPGNPLDHQITNE	CTAGE9	561	A4FU28
PRGPGNPLDHQITNE	CTAGE15	561	A4D2H0
HPPPQLGQSVGSQND	NEDD9	301	Q14511
EEQGLLPNGEPSQHS	AFAP1L2	76	Q8N4X5
AAPQAEHQGLPVPGS	CEP170B	641	Q9Y4F5
DEAAAQPGPSHPLPN	DAXX	16	Q9UER7
SGNNPPTHLSLDPTN	DAXX	156	Q9UER7
LLNPHTGQPFVNPDG	ARPP21	481	Q9UBL0
ELAQPSGGHLPQASP	ATG2A	1296	Q2TAZ0
NTLLPLGGDHQPEPS	ADAMTS12	1246	P58397
GQPFLPTHTQPNLQG	RBM33	566	Q96EV2
IPPLDPHENGNNGTI	RAB31	166	Q13636
VQPQADPHGLVQPGA	QRICH2	756	Q9H0J4
LSQSPHSVPGGPQAQ	KAT6B	1861	Q8WYB5
QPALAGADNPEHSPP	CYREN	81	Q9BWK5
PADPASPQHQLAGPA	PNPLA2	471	Q96AD5
PDAPNALHILDGPEQ	PIP5KL1	326	Q5T9C9
PNLSGIPGESNRAPH	FAM156A	136	Q8NDB6
QNNNHSGNKPDPPPV	MAP7	46	Q14244
HAPLPQGDGNEDSPG	FLCN	26	Q8NFG4
NAANATQDPGHLPPD	GPSM1	166	Q86YR5
FGPQGTISPLHQDPQ	KDM8	311	Q8N371
DNQSGSPHELGPQFP	KCNH6	741	Q9H252
NGINHSPPTLNGAPS	CBFA2T2	71	O43439
HPQSLQQPQGLGHPQ	FAM222B	186	Q8WU58
QGHPDGTPPKLDTAN	IL16	751	Q14005
PPHPHNNGQNLGELE	DCAF5	841	Q96JK2
SGPLSHPNPELNEAA	LHX5	386	Q9H2C1
PLTPPSQHQEAGAGD	MICAL1	681	Q8TDZ2
TQPHLQPRSGAPSQG	GLI2	1201	P10070
PHGAPALSNGPQTQA	KMT2B	721	Q9UMN6
QPPASLQTGNHSNGP	NOL4L	351	Q96MY1
DQVLPGLHPPSLADN	CASKIN2	446	Q8WXE0
RGSGHSQEQPAPQPS	CASKIN2	706	Q8WXE0
LSPQEGPPNHSTSQG	PIK3C2B	96	O00750
QLPSTGGHPGTAQPE	OBSCN	7006	Q5VST9
PVLNTGHPLGVNSDP	DERPC	36	P0CG12
VPGNITDPINNHQPG	ADAMTS3	116	O15072
PGPNSHNSNTPGIRE	HCK	61	P08631
RGHLLQPPDPGLTSN	ETV7	156	Q9Y603
QPPDPGLTSNFGHLD	ETV7	161	Q9Y603
PHLGTDPSNLGGQPL	CACNA1G	2281	O43497
SPQNHTLQAPGEPAP	FAM193B	621	Q96PV7
PHGPGLNPNASTGQE	FN1	2191	P02751
DASHPGASQPLQEPG	DUX4L9	346	Q6RFH8
QQPQALAPGRGPSHS	CEACAM3	191	P40198
SAQPQLADQVPPLGH	DNAJC13	2036	O75165
GVQNGPPASPTLAHE	MARK4	586	Q96L34
PGSLSHQNPDILPTN	ITIH6	741	Q6UXX5
SPNDSEHGPNPILGS	HDAC7	211	Q8WUI4
HGDPQSLDPPEVSNA	DPP6	226	P42658
ASGNHLNPEPNQPAP	BICRA	56	Q9NZM4
PQERSQQPLSAEGPH	BICRA	701	Q9NZM4
QAPPLSQAQGHPGIQ	SEC24C	186	P53992
DPQQGRTHQAAPGAP	SDK1	1791	Q7Z5N4
NINLGPSGNPHAKPT	SGK3	146	Q96BR1
PPGINSSQSLPVDNH	CFAP47	1606	Q6ZTR5
PAQELSPTPGGTAHQ	CEP131	376	Q9UPN4
NTGGLEPVHPASLPD	IRF2BP2	481	Q7Z5L9
SHPEAQEALGPPLNI	COA1	56	Q9GZY4
PGPGPLQTDLHAQRS	POM121L1P	86	Q3SYA9
PLTPLAQQDGLSAPH	PKD1	556	P98161
QPPDGDHSPGNHEQS	PEX16	151	Q9Y5Y5
QGDSISSQLGPIHPP	KHSRP	126	Q92945
HPDGDVPPQGEDNLL	HSFX1	81	Q9UBD0
VSPQNNHSPDPGLSN	KIF13B	1431	Q9NQT8
AAGGPPHPQLNKSQS	SYN1	651	P17600
PNHGDSPNLLIADNP	UTY	711	O14607
LNPGDHEDTRNALPP	SPHKAP	366	Q2M3C7
APELNGGPQHALPSS	PPARD	26	Q03181
LPGALQARPGPHTQD	SFTPB	181	P07988
PPQQLSAATPHGIND	NKX6-1	86	P78426
AIDHNGPPLSPQETD	RIC8B	211	Q9NVN3
PQTLAGGNPETAQPH	ARHGAP17	776	Q68EM7
GGNPETAQPHAGTLP	ARHGAP17	781	Q68EM7
AEPRPGAGSLQHAQP	PDPK1	56	O15530
RGNPALSDPGTPDQH	POU6F2	66	P78424
PRDQQGPGTLAQPAH	MIIP	266	Q5JXC2
PPHGSPGLAPNQQNI	NCOA3	466	Q9Y6Q9
SPQLLDPADRPGSQH	SIM1	416	P81133
REGSPGSQQHPPSQK	SHROOM2	971	Q13796
QPSPPNSDSGQDAHP	SPINDOC	146	Q9BUA3
HQGQQLPLGDPSCVP	OCSTAMP	456	Q9BR26
APQLVPGNPAGHAEQ	KIF25	246	Q9UIL4
LGPGTEQQGSHLNPE	AARS2	646	Q5JTZ9
GNTAEQPPSPAQLSH	SATB1	276	Q01826
QNPNSAAALPGSLHP	SP8	221	Q8IXZ3
LLGQTPPEDNHPDLS	B3GNT2	181	Q9NY97
HPLSPDQPNGGTLEN	CLEC11A	281	Q9Y240
PQISTNGPEHQPNGE	CLCA2	841	Q9UQC9
NHLSPQQGGATPQVP	SENP3	166	Q9H4L4
HLSSQAGGLPPQDTP	TRAF3IP3	141	Q9Y228
LHASREGPQPPGAEN	nan	46	Q9BRP9
HNPLSESPQGTAPLG	TEX13D	331	A0A0J9YY54
EHDDPTGQPGAPQLT	ZNF488	121	Q96MN9
GEHLSDQENAPPILP	TTBK1	361	Q5TCY1
NPGLTQDPGLHENPG	SPEM3	701	A0A1B0GUW6
QDPGLHENPGLAPNQ	SPEM3	706	A0A1B0GUW6
QTPHNPSGPGLGNQL	STAG3	1156	Q9UJ98
SLPEGPGQQGHTPQL	SARG	216	Q9BW04
NHAALPSQPGTLPDL	TCF3	461	P15923
LANQSEQPPPSGGLH	PLEKHD1	271	A6NEE1
EQPPPSGGLHSNLRQ	PLEKHD1	276	A6NEE1
NPQGESHPPLNLAFL	STAG2	986	Q8N3U4
NHTLLPPGDPSLNGS	ROBO3	41	Q96MS0
HPGVTQAPQPLGESQ	WDFY4	976	Q6ZS81
HLVAGQGNPEPTELP	TMUB2	86	Q71RG4
AGVPHPPQGENLAAD	TACC2	776	O95359
SQPSAGPQLNALPDH	TTPA	6	P49638
PQNLGTPGLLHPQTS	CAD	1901	P27708
GPTPRNGNKSDQAHP	TOP3A	401	Q13472
NNPPANALRGGASHP	ZNFX1	36	Q9P2E3
SLGLPPHQPEAQAQS	ZNF446	236	Q9NWS9
ASHQTPQGDPLGPQD	ZNF469	2401	Q96JG9
HFQQLGPPAPGATSN	ZNF687	691	Q8N1G0
TLHPPGNIPESGQNQ	WNK1	2166	Q9H4A3
NGSPLPERAHPEVNG	TET2	36	Q6N021
EQAEPPRNPGSHLGL	XIRP1	1791	Q702N8
QASPNPVPGDGLHRA	TOE1	426	Q96GM8
LPGHDLQSLSQGNPE	TSPYL5	331	Q86VY4